WhichRecall
Class IIReported 2025-02-19

Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-442-15

Recalled by AvKARE

Reason for Recall

Out of Specification for Dissolution

Advertisement
Recall Number
D-0224-2025
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-01-21
Reported
2025-02-19
Distribution
Nationwide in the USA
Code Info
Lot 45279, Exp 03/31/2025
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement